http://bit.ly/2AbPxuj

The US Food and Drug Administration has issued 14 observations after inspecting the drug firm's manufacturing facility at Moraiya in Ahmedabad.

from Markets http://bit.ly/2Vf2obE

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads